Taiwan Biotech Called Out for Environmental Monitoring

Drug Industry Daily
A A
The FDA warned finished drugmaker Taiwan Biotech for significant CGMP violations at its facility in Taoyuan City, Taiwan, including inadequate environmental monitoring.

To View This Article:

Login

Subscribe To Drug Industry Daily